Integra LifeSciences (IART) PT Lowered to $18 at BMO Capital
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $16.72 +1.70%
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
BMO Capital analyst Vik Chopra lowered the price target on Integra LifeSciences (NASDAQ: IART) to $18.00 (from $19.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference
- CIENA (CIEN) PT Lowered to $394 at UBS on Group Multiple Compression
- Equity Bancshares (EQBK) PT Raised to $54 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
